SEC Form 4 · accession 0001179110-15-011910
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank E Thomas
Officer — President & COO
Period of report
Aug 5, 2015
Accepted (ET)
Aug 7, 2015 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2015 | M | 15,000 | $14.91 | A | 124,309 | D | |
| Common StockF2 | Aug 5, 2015 | S | 15,000 | $66.85 | D | 109,309 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $14.91 | Aug 5, 2015 | M | 15,000 | D | — | Aug 1, 2021 | Common Stock | 15,000 | 45,000 | D |
Explanation of responses
- F1The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2015.
- F2This option vests and becomes exercisable in four equal annual installments beginning August 1, 2012.